Table 3.
Multiple regression derived coefficients (b) and P values for vascular reactivity results
| Flow-mediated vasodilation |
Nitroglycerin- induced vasodilation |
Forearm resting skin blood flow |
Forearm post- acetylcholine blood flow |
Forearm post- sodium blood flow |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| b | P value | b | P value | b | P value | b | P value | b | P value | |
| Age | −0.027 | NS | −0.021 | NS | 0.003 | NS | 0 | NS | 0.009 | 0.06 |
| Gender | ||||||||||
| Men vs. women | −1.32 | 0.005 | −1.43 | 0.06 | 0.03 | NS | −0.11 | NS | 0.04 | NS |
| Studied groups | ||||||||||
| LD vs. LC | −1.68 | NS | −0.15 | NS | 0.02 | NS | 0 | NS | 0.31 | 0.09 |
| OC vs. LC | −2.44 | 0.003 | 2.97 | 0.03 | −0.18 | 0.04 | −0.20 | NS | −0.23 | NS |
| OD vs. LC | −2.09 | 0.04 | −2.43 | NS | 0.07 | NS | 0 | NS | 0.15 | NS |
| OC vs. LD | −0.75 | NS | 3.11 | 0.07 | −0.19 | 0.05 | −0.20 | NS | −0.54 | 0.001 |
| OD vs. LD | −0.41 | NS | −2.29 | 0.02 | 0.01 | NS | 0 | NS | −0.16 | 0.06 |
| OD vs. OC | 0.35 | NS | −5.39 | 0.001 | 0.20 | 0.04 | 0.20 | NS | 0.38 | 0.02 |
| Antihypertensives (ACE inhibitors and ARBs) |
−1.20 | 0.04 | −1.69 | 0.09 | −0.02 | NS | 0.08 | NS | −0.09 | NS |
| Oral antidiabetic treatment | −0.43 | NS | 0.08 | NS | 0.05 | NS | 0.03 | NS | 0.11 | NS |
| Insulin treatment | −0.16 | NS | −1.29 | NS | 0.08 | NS | 0.03 | NS | −0.10 | NS |
| Statin treatment | 0.68 | NS | 1.44 | NS | −0.11 | 0.03 | −0.09 | NS | −0.18 | 0.03 |
ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blockers; OC, obese controls; LC, nonobese controls; LD, nonobese DM patients.